{"DataElement":{"publicId":"3134022","version":"1","preferredName":"Breast Tumor Pathologic Grouping Stage","preferredDefinition":"Code to represent the extent of breast carcinoma based on the patient's primary tumor (T), nodes (N), and sites of metastatic disease (TNM).","longName":"3134018v1.0:3134020v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3134018","version":"1","preferredName":"Breast Tumor Pathologic Stage Grouping","preferredDefinition":"information related to the assessment of a neoplasm of the breast based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)_Caused by or altered by or manifesting disease or pathology._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"2206465v1.0:2230144v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206465","version":"1","preferredName":"Breast Neoplasm","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12971:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F64A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230144","version":"1","preferredName":"Pathologic Stage Grouping","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C25610:C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CCE-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F0AE4D0-7A75-674F-E040-BB89AD437513","latestVersionIndicator":"Yes","beginDate":"2010-08-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-30","modifiedBy":"TAYLORT","dateModified":"2019-05-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3134020","version":"1","preferredName":"Breast Carcinoma Pathologic Stage","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  _Caused by or altered by or manifesting disease or pathology._the stage grouping for a breast tumor, as defined by the AJCC Cancer Staging Manual, 6th Ed.","longName":"3134020v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Stage Unknown","ValueMeaning":{"publicId":"3133771","version":"1","preferredName":"Stage Unknown","longName":"3133771","preferredDefinition":"Not known, not observed, not recorded, or refused.: The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EC079DB-DE3C-1143-E040-BB89AD4372AF","latestVersionIndicator":"Yes","beginDate":"2010-08-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8F0AE4D0-7ABB-674F-E040-BB89AD437513","beginDate":"2010-08-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-30","modifiedBy":"ONEDATA","dateModified":"2010-08-30","deletedIndicator":"No"},{"value":"IB","valueDescription":"T0, N1mi, M0 OR T1* N1mi, M0","ValueMeaning":{"publicId":"3134021","version":"1","preferredName":"T0, N1mi, M0 OR T1* N1mi, M0","longName":"3134021","preferredDefinition":"* [Note: T1 includes T1mi]","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F0AE4D0-7AC5-674F-E040-BB89AD437513","latestVersionIndicator":"Yes","beginDate":"2010-08-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8F0AE4D0-7ADE-674F-E040-BB89AD437513","beginDate":"2010-08-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-30","modifiedBy":"ONEDATA","dateModified":"2010-08-30","deletedIndicator":"No"},{"value":"0","valueDescription":"Tis, N0, M0","ValueMeaning":{"publicId":"2576682","version":"1","preferredName":"Tis, N0, M0","longName":"2576682","preferredDefinition":"Tis, N0, M0","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F897-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-24","modifiedBy":"CAMPBELB","dateModified":"2005-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8F0AE4D0-7AE8-674F-E040-BB89AD437513","beginDate":"2003-05-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-30","modifiedBy":"ONEDATA","dateModified":"2010-08-30","deletedIndicator":"No"},{"value":"IA","valueDescription":"T1*, N0, M0","ValueMeaning":{"publicId":"2576683","version":"1","preferredName":"T1*, N0, M0","longName":"2576683","preferredDefinition":"* [Note: T1 includes T1mic]","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F898-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-24","modifiedBy":"CAMPBELB","dateModified":"2005-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8F0AE4D0-7AFD-674F-E040-BB89AD437513","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-30","modifiedBy":"ONEDATA","dateModified":"2010-08-30","deletedIndicator":"No"},{"value":"IIA","valueDescription":"T0, N1, M0 OR T1*, N1, M0 OR T2, N0, M0","ValueMeaning":{"publicId":"2576684","version":"1","preferredName":"T0, N1, M0 OR T1*, N1, M0 OR T2, N0, M0","longName":"2576684","preferredDefinition":"* [Note: T1 includes T1mic]","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F899-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-24","modifiedBy":"CAMPBELB","dateModified":"2005-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8F0AE4D0-7B08-674F-E040-BB89AD437513","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-30","modifiedBy":"ONEDATA","dateModified":"2010-08-30","deletedIndicator":"No"},{"value":"IIB","valueDescription":"T2, N1, M0 OR T3, N0, M0","ValueMeaning":{"publicId":"2576685","version":"1","preferredName":"T2, N1, M0 OR T3, N0, M0","longName":"2576685","preferredDefinition":"T2, N1, M0 OR T3, N0, M0","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F89A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-24","modifiedBy":"CAMPBELB","dateModified":"2005-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8F0AE4D0-7B13-674F-E040-BB89AD437513","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-30","modifiedBy":"ONEDATA","dateModified":"2010-08-30","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"T0, N2, M0 OR T1*, N2, M0 OR T2, N2, M0 OR T3, N1, M0 OR T3, N2, M0","ValueMeaning":{"publicId":"2576686","version":"1","preferredName":"T0, N2, M0 OR T1*, N2, M0 OR T2, N2, M0 OR T3, N1, M0 OR T3, N2, M0","longName":"2576686","preferredDefinition":"* [Note: T1 includes T1mic]","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F89B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-24","modifiedBy":"CAMPBELB","dateModified":"2005-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8F0AE4D0-7B1E-674F-E040-BB89AD437513","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-30","modifiedBy":"ONEDATA","dateModified":"2010-08-30","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"T4, N0, M0 OR T4, N1, M0 OR T4, N2, M0","ValueMeaning":{"publicId":"2576687","version":"1","preferredName":"T4, N0, M0 OR T4, N1, M0 OR T4, N2, M0","longName":"2576687","preferredDefinition":"T4, N0, M0 OR T4, N1, M0 OR T4, N2, M0","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F89C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-24","modifiedBy":"CAMPBELB","dateModified":"2005-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8F0AE4D0-7B29-674F-E040-BB89AD437513","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-30","modifiedBy":"ONEDATA","dateModified":"2010-08-30","deletedIndicator":"No"},{"value":"IIIC","valueDescription":"Any T, N3, M0","ValueMeaning":{"publicId":"2576681","version":"1","preferredName":"Any T, N3, M0","longName":"2576681","preferredDefinition":"** [Note: Stage IIIC breast cancer includes patients with any T stage who have pN3 disease. Patients with pN3a and pN3b disease are considered operable and are managed as described in the section on Stage I, II, IIIA, and operable IIIC breast cancer. Patients with pN3c disease are considered inoperable and are managed as described in the section on Inoperable stage IIIB or IIIC or inflammatory breast cancer.]","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F896-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-24","modifiedBy":"CAMPBELB","dateModified":"2005-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8F0AE4D0-7B34-674F-E040-BB89AD437513","beginDate":"2005-10-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-30","modifiedBy":"ONEDATA","dateModified":"2010-08-30","deletedIndicator":"No"},{"value":"IV","valueDescription":"Any T, Any N, M1","ValueMeaning":{"publicId":"2576688","version":"1","preferredName":"Any T, Any N, M1","longName":"2576688","preferredDefinition":"Any T, Any N, M1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F89D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-24","modifiedBy":"CAMPBELB","dateModified":"2005-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8F0AE4D0-7B3F-674F-E040-BB89AD437513","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-30","modifiedBy":"ONEDATA","dateModified":"2010-08-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3134019","version":"1","preferredName":"Breast Carcinoma Pathologic Stage","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter's syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002:Pathologic; caused by or altered by or manifesting disease or pathology.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C4872:C25610:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F0AE4D0-7A8A-674F-E040-BB89AD437513","latestVersionIndicator":"Yes","beginDate":"2010-08-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-30","modifiedBy":"ONEDATA","dateModified":"2010-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 7th Ed., 2009","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F0AE4D0-7A9B-674F-E040-BB89AD437513","latestVersionIndicator":"Yes","beginDate":"2010-08-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-30","modifiedBy":"ZHANGWE","dateModified":"2017-10-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"5280816","version":"1","longName":"UWI2015-05-01","context":"DCP"}]},{"publicId":"5542681","version":"1","longName":"EDRN_CDE_Project","context":"EDRN","ClassificationSchemeItems":[{"publicId":"5543567","version":"1","longName":"Reused-CDEs","context":"EDRN"},{"publicId":"5542682","version":"1","longName":"Biospecimen CDEs","context":"EDRN"}]}],"AlternateNames":[{"name":"EDRN","type":"USED_BY","context":"EDRN"},{"name":"Reused-CDEs.Breast_Neoplasm.SPECIMEN_BREAST_STAGEGROUPPATH_CODE_1708","type":"UML Qualified Attr","context":"EDRN"},{"name":"Breast_Neoplasm:SPECIMEN_BREAST_STAGEGROUPPATH_CODE_1708","type":"UML Class:UML Attr","context":"EDRN"},{"name":"DCP","type":"USED_BY","context":"DCP"}],"ReferenceDocuments":[{"name":"Breast Stage","type":"Preferred Question Text","description":"Breast Stage","url":null,"context":"NCIP"},{"name":"DCP Question Text","type":"Alternate Question Text","description":"Stage (historical context)","url":null,"context":"DCP"},{"name":"DCP-Text-1","type":"Alternate Question Text","description":"Pathologic Stage (historical context)","url":null,"context":"DCP"}],"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 7th Ed., 2009","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8F0AE4D0-7B4A-674F-E040-BB89AD437513","latestVersionIndicator":"Yes","beginDate":"2010-08-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-30","modifiedBy":"ZHANGWE","dateModified":"2020-12-17","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 8/2010","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}